Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pituitrin is a proprietary name for an extract of bovine posterior pituitary hormones, primarily containing oxytocin and vasopressin. Historically, it was used in obstetrics to induce labor and treat postpartum hemorrhage due to the uterotonic effects of oxytocin and the vasoconstrictive properties of vasopressin. In addition to its use in obstetrics, it has been employed as a vasopressor in perioperative management for conditions such as pulmonary hypertension and massive hemoptysis. The mechanism of action involves stimulation of uterine smooth muscle contraction (oxytocin) and constriction of systemic blood vessels (vasopressin), leading to increased systemic vascular resistance and blood pressure[1][2][3][6]. Pituitrin has largely been replaced by purified or synthetic preparations but may still be encountered in some clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pituitrin.